Zhou Xinxin, You Yingting, Ren Lizhen, Akhtar Muhammad, Ji Hui, Wang Tingyang, Meng Na, Fan Xin, Yang Shumin, Zhou Zutao, Xiao Yuncai, Shi Deshi
College of Veterinary Medicine, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430000, China.
Basic Veterinary Medicine, College of Animal Science and Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Poult Sci. 2025 Jul 4;104(10):105537. doi: 10.1016/j.psj.2025.105537.
The predominant objective in large-scale poultry farming has consistently been to enhance broiler. In this context, the supplementing of probiotics, specifically Lactobacilli, has emerged as a promising strategy to improve production efficiency. Numerous studies have demonstrated that Lactobacilli could modulate intestinal microbiota. To identify effective growth-promoting Lactobacilli, the present study replicated the "high body weight" phenotype of broiler chickens through fecal microbiota transplantation (FMT) and subsequently isolated target strains from FMT recipients exhibiting high body weight. The results demonstrated that Lactobacillus gallinarum CD-13 (CD-13) produced protease and exhibited inhibitory (P < 0.05) effects against pathogenic Gram-positive and Gram-negative bacteria. In vivo experimentation revealed that an average daily gain of broilers in the CD-13 group was increased by 17.72 %, along with enhanced (P < 0.05) duodenal villus height in the CD-13 group compared to the control group (Ctrl). Furthermore, the antioxidant capacity of broilers was improved, as evidenced by elevated levels of catalase (CAT) (P < 0.05) and glutathione peroxidase (GSH-Px) (P < 0.05) in the serum, while the level of malondialdehyde (MDA) was reduced (P < 0.05). 16S rRNA analysis revealed, the CD-13 group exhibited an increase (P < 0.05) in the diversity index of the intestinal microbiota, an elevated Bacteroidota/Firmicutes ratio, and the relative abundance of Bacteroides, whereas a decrease in the relative (P < 0.05) abundance of Alistipes compared with the Ctrl group. In conclusion, CD-13 demonstrated the capacity to enhance broiler growth performance through modulation of the intestinal microbiota and improvement of antioxidant capacity, thereby reducing of intestinal inflammation. The findings of this investigation substantiated the probiotic properties of CD-13 and provided a theoretical foundation for its potential application as a probiotic additive in the poultry industry.
大规模家禽养殖的主要目标一直是提高肉鸡产量。在此背景下,补充益生菌,特别是乳酸杆菌,已成为提高生产效率的一种有前景的策略。众多研究表明,乳酸杆菌可调节肠道微生物群。为了鉴定有效的促生长乳酸杆菌,本研究通过粪便微生物群移植(FMT)复制了肉鸡的“高体重”表型,随后从表现出高体重的FMT受体中分离出目标菌株。结果表明,鸡源乳酸杆菌CD-13(CD-13)产生蛋白酶,并对致病性革兰氏阳性和革兰氏阴性细菌表现出抑制作用(P<0.05)。体内实验表明,与对照组(Ctrl)相比,CD-13组肉鸡的平均日增重提高了17.72%,十二指肠绒毛高度也有所增加(P<0.05)。此外,肉鸡的抗氧化能力得到改善,血清中过氧化氢酶(CAT)(P<0.05)和谷胱甘肽过氧化物酶(GSH-Px)(P<0.05)水平升高,而丙二醛(MDA)水平降低(P<0.05)证明了这一点。16S rRNA分析显示,与Ctrl组相比,CD-13组肠道微生物群的多样性指数增加(P<0.05),拟杆菌门/厚壁菌门比例升高,拟杆菌的相对丰度增加,而阿里斯杆菌的相对丰度降低(P<0.05)。总之,CD-13通过调节肠道微生物群和提高抗氧化能力,证明了其增强肉鸡生长性能的能力,从而减轻肠道炎症。本研究结果证实了CD-13的益生菌特性,并为其作为益生菌添加剂在家禽行业的潜在应用提供了理论基础。